ATRX and central nervous system cancer: Telomerase reverse transcriptase promoter (TERTp) mutations and alpha thalassemia/mental retardation syndrome X-linked (ATRX) mutations are mutually exclusive alterations in gliomas and both are functionally correlated with telomere length maintenance9.